Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01646762 · TERMINATED
Trial details
- NCT number
- NCT01646762
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-05
- Primary completion
- 2015-01-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.